Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7205506 | 7745184 | I | 7205506-8 | 20101216 | 20101222 | 20101231 | EXP | PHHO2010AU19331 | NOVARTIS PHARMACEUTICAL CORPORATION | 61 | YR | M | Y | 97.55 | KG | 20101231 | MD | AUSTRALIA |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7205506 | 1015449407 | PS | ZOLEDRONATE | 2 | INTRAVENOUS | 4MG | 021223 | ||||
| 7205506 | 1015449408 | SS | AFINITOR | 1 | ORAL | UNK | |||||
| 7205506 | 1015449409 | SS | LESCOL | 1 | ORAL | 120 MG | |||||
| 7205506 | 1015449410 | C | FRUSEMIDE | 2 | |||||||
| 7205506 | 1015449411 | C | RAMIPRIL | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 7205506 | 1015449407 | PROSTATE CANCER |
| 7205506 | 1015449408 | PROSTATE CANCER |
| 7205506 | 1015449409 | PROSTATE CANCER |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 7205506 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 7205506 | ABDOMINAL PAIN |
| 7205506 | DEHYDRATION |
| 7205506 | DIARRHOEA |
| 7205506 | FEBRILE NEUTROPENIA |
| 7205506 | NAUSEA |
| 7205506 | PYREXIA |
| 7205506 | RENAL IMPAIRMENT |
| 7205506 | VOMITING |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 7205506 | 1015449407 | 20100909 | 20101215 | 98 | DAY |